NAcM-COV

NAcM-COV is a specific, irreversible small molecule inhibitor targeting N-Acetyl-UBE2M interaction with DCN1 with IC50 of 28 nM in TR-FRET assays; shows highly selectivity with respect to other protein acetyl-amide-binding sites; inhibits NEDD8 ligation in vitro and in cells, and suppress anchorage-independent growth of a cell line with DCN1 amplification.

References 1. Scott DC, et al. Nat Chem Biol. 2017 Aug;13(8):850-857. View Related Products by Target Ubiquitin-conjugating Enzyme (E2)